Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Pharmaceutical and Device
Pharmaceutical Reps Seen By Fewer Physicians
At a time when the use of drugs and medicine are increasingly being used to beneficially treat Americans in our health care…
Ortho-McNeil Settlement and Corporate Integrity Agreement
Last week was not the only settlement agreement (AstraZeneca) signed between a pharmaceutical company and the Office of…
IOM Report: National Cancer Clinical Trials System for the 21st Century
“Advances in biomedical research continue to create significant opportunities for improving the detection, treatment, and…
CMSS Code of Interaction with Companies
The Council of Medical Specialty Societies (CMSS) which represents 32 leading medical professional societies, with a collective…
PDUFA 2012 – Background From PhRMA’s Perspective
In 2012 Congress will be revisiting Prescription Drug User Fee Act (PDUFA). In an effort to prepare the FDA is asking for comments…
IMS Reports Significant Global Pharmaceutical Sales Growth in Emerging…
IMS Health reported that the size of the global market for pharmaceuticals is expected to grow nearly $300 billion over the next…
Alzheimer’s Imaging Agents Offer Progress in Diagnosis of an Elusive…
While most doctors, patients, employers and the majority of Americans try to sift through over 2,000 confusing pages of the…
Milwaukee Journal Sentinel: Bias Reporting on Physician Industry…
The Milwaukee, Wisconsin Journal Sentinel continued on its track to discredit physicans working with industry by publishing…
Prescription Drug Sales 2009 – IMS Data
A recent report by data tracker IMS health found that:
· Generic drugs accounted for 75% of the U.S. prescription drug volume…
Physician Payment Sunshine: Pfizer Discloses Payments to Physicians
Continuing the ongoing trend of transparency and disclosure in the pharmaceutical industry, Pfizer Inc. released its payment…